Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression

Details for Australian Patent Application No. 2002246504 (hide)

Owner Response Genetics, Inc.

Inventors Danenberg, Kathleen, D.

Agent Shelston IP

Pub. Number AU-B-2002246504

PCT Pub. Number WO2002/057489

Priority 60/250,471 04.12.00 US; 09/877,178 11.06.01 US; 60/250,358 01.12.00 US

Filing date 9 November 2001

Wipo publication date 30 July 2002

Acceptance publication date 29 March 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/282 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002246504

29 March 2007 Application Accepted

  Published as AU-B-2002246504

2 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246505-TRANSLATION OF DIGITAL CONTENTS BASED ON RECEIVING DEVICE CAPABILITIES

2002246502-NOVEL NUCLEIC ACIDS AND POLYPEPTIDES